Are you a company specializing in health science technology and working to raise your Series A funding during the last quarter of 2022 or next year? The Ontario Bioscience Innovation Organization’s (OBIO) Capital Access Advisory Program (CAAP) is offering a nine-month program to help you structure your strategies, funding plans and presentations.

The OBIO competitive program is structured to cover three critical issues important to startups.

The companies admitted to the program will be guided by experts from the health science as well as investment and financial fields.

The companies in the program will get to pitch their projects at the next  OBIO Investment Summit, expected to be held in 2023. Investors from around the world participate in the summit.

The program is now looking for applications for its second cohort and the deadline is September 16, 2022. You find more details here.

The OBIO is a not-for profit organization promoting Ontario’s health science companies and the industry itself.


Leave a Reply

Your email address will not be published. Required fields are marked *